文献速递中医内科中药与中成药合理使用

中药治疗狼疮性肾炎:自身免疫发病机制的调控

Traditional Chinese medicine for lupus nephritis: modulation of autoimmune pathogenesis.
PubMed 文献 · Front Pharmacol · 2025-05-02

本综述检索PubMed和Web of Science至2024年6月7日,纳入31篇论文,总结7种中药复方和18种植物化学物调控狼疮性肾炎自身免疫发病机制的作用。其机制涉及调节免疫细胞活化、分化、凋亡及影响肾脏驻留细胞,以支持肾脏保护和免疫稳态。中药具有双向调节作用,激活调节性免疫细胞同时抑制致病因素,但部分研究结果不一致或不确定。

要点

  • 中药复方和植物化学物可通过调节免疫细胞和肾脏驻留细胞发挥治疗狼疮性肾炎的潜力。
  • 中药具有双向调节特点,激活调节性免疫细胞并抑制致病因素。
  • 现有研究存在局限,未来需关注免疫抑制和肾脏保护效应及临床转化与标准化。

核心结论

  • 中药复方和植物化学物在调控狼疮性肾炎免疫细胞及肾脏驻留细胞方面具有潜力和意义。
  • 未来研究应聚焦中药复方和植物化学物的免疫抑制与肾脏保护效应,并加强临床转化和标准化。

研究设计与样本

  • 综述检索PubMed和Web of Science截至2024年6月7日,纳入31篇研究论文。
  • 研究质量依据Good Automated Manufacturing Practice指南由两位作者共同评估。

主要发现

  • 共总结7种中药复方和18种植物化学物调控狼疮性肾炎自身免疫发病机制。
  • 机制涉及调节免疫细胞活化、分化、凋亡以及影响肾脏驻留细胞以支持肾脏保护和免疫稳态。
  • 中药表现双向调节,激活调节性免疫细胞同时抑制致病因素。
  • 部分研究结果不一致或不确定。

临床怎么用

  • 中药可作为狼疮性肾炎的辅助治疗,因其低毒性和长期管理中的多样治疗效应。

局限性

  • 现有研究存在局限性,部分发现不一致或不确定。
  • 未来需增强中药的临床转化和标准化。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Lupus nephritis (LN) is an immune complex glomerulonephritis commonly associated with systemic lupus erythematosus. Traditional Chinese medicine (TCM) has emerged as a promising adjuvant therapy for LN, due to its low toxicity and diverse therapeutic effects for long-term management. MATERIALS AND METHODS: A comprehensive search of PubMed and Web of Science was conducted up to 7 June 2024, using keywords related to lupus nephritis, traditional Chinese medicine, immune cells, and kidney resident cells. Study quality were assessed based on Good Automated Manufacturing Practice guidelines, with evaluations jointly conducted by two authors. RESULTS: This review includes 31 research papers and summarizes seven herbal formulas and 18 phytochemicals that modulate the autoimmune pathogenesis of LN. Their mechanisms involve regulating immune cells activation, differentiation, apoptosis, as well as influencing resident kidney cells to support renal protection and immune homeostasis. Since TCM exhibit bidirectional regulation, they activate regulatory immune cells while suppress pathogenic factors. Inconsistent or inconclusive findings are discussed. CONCLUSION: This review summarizes current research on herbal formulas and phytochemicals in immune cells and kidney resident cells in LN, highlighting the potential and significance of TCM treatment. It also addresses the limitations of existing studies and suggests that future research should focus on exploring the immunosuppressive and kidney-protective effects of herbal formulas and phytochemicals, as well as enhancing the clinical translation and standardization of TCM.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Huang Z, Li X, Zhu Q, et al. Traditional Chinese medicine for lupus nephritis: modulation of autoimmune pathogenesis. Front Pharmacol. 2025. PMID: 40385489. doi:10.3389/fphar.2025.1523272

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。